Liberator, Inc. (LUVU) Announces Strong Financial Results for First Quarter Fiscal 2013
Liberator, a leading producer of sexual health and wellness products, recently reported their Q1 2013 financials for the period ended…
Blog
GlobalWise Investments, Inc. (GWIV) Reports Strong Financial Results with Double-Digit Growth
GlobalWise Investments and its wholly owned subsidiary Intellinetics, an enterprise content management (“ECM”) software development, sales, and marketing company, just…
Nanosphere, Inc. (NSPH) Receives FDA Clearance to Market the Verigene CYP2C19 Test
Nanosphere, a leading provider of advanced molecular diagnostics systems, announced that the U.S. Food and Drug Administration has granted 510(k)…
Jonathan B. Rome Named COO of Boston Therapeutics, Inc. (BTHE)
Yesterday, Boston Therapeutics announced that Mr. Jonathan B. Rome has been named as its Chief Operating Officer. David Platt, Ph.D.,…
Quaterra Resources, Inc. (QMM) Shows Solid Intervals Like 2.62 feet at 54.5 Ounces Per Ton Silver in Newly Discovered Zone at Nieves Project
Quaterra Resources today reported excellent evidence of their model for the Nieves silver property in northern Zacatecas, Mexico, as assay…
Consorteum Holdings, Inc. (CSRH) Files Form 10-K Report with SEC
Consorteum Holdings just announced that it filed its Report on Form 10-K for the fiscal year ended June 30, 2012,…
Cardium Therapeutics, Inc. (CXM) Presents Q3 Results, Plus Update on Business Activity
Cardium Therapeutics, a health sciences and regenerative medicine company, today presented financial results for the third quarter, ended September 30,…
DoMark International, Inc. (DOMK) Rescues the Good Idea
It’s an unfortunate fact of business life that good ideas, even great ideas, are a dime a dozen. There isn’t…
Cardium Therapeutics, Inc. (CXM) to Present Excellagen Posters at Desert Foot 9th Annual High Risk Diabetic Foot Conference
Cardium Therapeutics, an asset-based health sciences and regenerative medicine company, announced this morning that the company will be displaying two…
VistaGen Therapeutics, Inc. (VSTA) Announces Enhancement of Predictive Liver Toxicology and Drug Metabolism Bioassay System
VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening, today announced…